Carl-Henrik Heldin

Carl-Henrik Heldin (born 9 August 1952) is a Swedish molecular biologist and medical researcher. He has been director of the Uppsala branch of Ludwig Cancer Research since 1986 and professor in molecular cell biology at the medical faculty of Uppsala University since 1992. He is vice-president of the European Research Council since 2011[1] and was appointed chairman of the Nobel Foundation in 2013.[2][3]

His research has focused on the mechanisms of signal transduction by growth regulatory factors like platelet-derived growth factor (PDGF) and transforming growth factor (TGF).

He was senior editor of Cancer Research from 2003 to 2009.[4]

Membership in Learned societies and Doctor honoris causa

He is a member of the following learned societies

He is honorary doctor of University of Patras, University of Helsinki, University of Turku and University of Heidelberg.[6]

Awards

Heldin has been awarded several prizes, including

Personal life

Heldin is married and has two children born in 1982 and 1988.[4]

References

  1. Press Release, 12 April 2011: New Vice Presidents for the European Research Council European Research Council. Retrieved 22 September 2013
  2. Klas Leffler (21 April 2013): Calle får Silvia till bordet varje år Allehanda.se. Retrieved 22 September 2013 (Swedish)
  3. Carl-Henrik Heldin new Chairman of the Board of the Nobel Foundation
  4. 1 2 CURRICULUM VITAE Academica Europaea. Retrieved 22 September 2013(pdf)
  5. Medical sciences Royal Swedish Academy of Sciences. Retrieved 22 September 2013
  6. 1 2 3 Carl-Henrik Heldin Academia Europaea. Retrieved 22 September 2013
  7. The Finnish Society of Sciences and Letters Retrieved 22 September 2013
  8. "Medaljförläningar" [Medal presentations] (in Swedish). Royal Court of Sweden. 2016-01-28. Retrieved 2 February 2016.
Non-profit organization positions
Preceded by
Marcus Storch
Chairman of the Nobel Foundation
2013–present
Incumbent
This article is issued from Wikipedia - version of the 2/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.